Obesity Drugs Will Get Broad Commercial Coverage In 2025 Despite Cost Concerns, Survey Says

The Business Group on Health survey also highlights employers’ complicated attitudes on prescription drug rebates in their health benefit programs.

Employers' Health Spending Rose 7% In 2023, Driven By Pharmacy Costs. • Source: Shutterstock

More from Market Access

More from Pink Sheet